Top Markets
Coin of the day
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Classifica tra le azioni #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Prezzo delle azioni
$0.08765138
Ultima sincronizzazione: 2025-12-23
Capitalizzazione di mercato
$1.11M
Variazione (1 giorno)
0.45%
Variazione (1 anno)
-28.78%
Paese
CA
Scambia Psyence Group Inc. (PSYG)

Categoria

Rapporto P/S per Psyence Group Inc. (PSYG)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Psyence Group Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Psyence Group Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
14.97 -
US
6.31 -
US
7.06 -
US
4.66 -
CH
4.90 -
US